Retinal Consultants Medical Group

What Retinal Consultants Medical Group does

Retinal Consultants Medical Group (RCMG) is a Sacramento-headquartered, physician-owned subspecialty medical practice founded in 1977 that diagnoses and treats diseases of the retina, macula, and vitreous. The practice operates 13 clinic locations across Northern California, employs 18 board-certified, fellowship-trained retina specialists recruited from institutions including Harvard, Stanford, Johns Hopkins Wilmer Eye Institute, USC Doheny, Columbia, UCLA, Bascom Palmer, and Cleveland Clinic, and includes an ambulatory retina surgery center at its Sacramento Greenback Lane site. RCMG runs 30 active clinical trials and has participated in landmark research contributing to FDA approvals for wet macular degeneration, retinal vein occlusions, and diabetic macular edema treatments, including early access to Genentech's Susvimo Port Delivery System.

The practice offers a comprehensive care platform spanning diagnostics (retinal photography, angiography, ophthalmic ultrasound, OCT, and ERG/VEP testing), in-office treatments (intravitreal anti-VEGF injections, panretinal photocoagulation, focal laser, photodynamic therapy, photobiomodulation therapy for dry AMD, and AREDS/AREDS2 supplements), and surgical procedures (vitrectomy, scleral buckle, retinal detachment repair, and Susvimo PDS implantation). Its service catalog covers diabetic retinopathy, age-related macular degeneration, retinal tears and detachments, vein occlusions, macular holes and puckers, and rare conditions including retinitis pigmentosa and retinopathy of prematurity.

RCMG generates revenue through insurance reimbursements (Medicare, Medi-Cal, and most private insurance plans), patient self-pay, and CareCredit financing, with payments collected via the InstaMed portal. The go-to-market model relies on referrals from comprehensive ophthalmologists, optometrists, and primary care physicians complemented by direct patient appointments and same-day urgent access. The practice has been part of Retina Consultants of America since 2020 and serves a multilingual patient base across English, Spanish, Mandarin, Russian, Hmong, Korean, Vietnamese, and Ukrainian speakers.

Name

Retinal Consultants Medical Group

Legal name

Retinal Consultants Medical Group

Website

https://retinalmd.com

Company type

Private

Founded year

1977

Operating status

Operating

Headcount range

101–250 employees

Short description

Retinal Consultants Medical Group is a Sacramento-based, physician-owned retina subspecialty practice operating 13 clinics across Northern California with 18 fellowship-trained specialists, delivering diagnostics, in-office treatments, and vitreoretinal surgery for AMD, diabetic retinopathy, and related conditions.

Ownership category

akta.pro rank

Product category

Specialty Ophthalmology / Vitreoretinal Care

NAICS

Offices of Physicians (except Mental Health Specialists) (621111), Diagnostic Imaging Centers (621512)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industries

Ocular Imaging & Diagnostic Testing Centers (HLAKAKAN), Ophthalmology Surgery Centers (HLAFAIAF), Ophthalmology Clinics (Medical & Surgical Eye Care) (HLAKAKAC)

Keywords

• Retinal disease treatment
• Vitreoretinal surgery
• Ophthalmologic diagnostic services
• Macular degeneration care
• Retinal vascular disease

Headquarters

HQ city

Sacramento

HQ country

United States

HQ region

North America

Offices13 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Patient Care Services: Medical practice providing diagnostic, therapeutic, and surgical retina care to patients. Revenue generated through insurance reimbursements (Medicare, Medi-Cal, private insurance) and patient payments.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Retinal Consultants Medical Group is a subspecialty ophthalmology practice that diagnoses and treats diseases of the retina and vitreous, including age-related macular degeneration, diabetic retinopathy, retinal detachment, and retinal vascular occlusions. It delivers this care through diagnostic imaging, in-office procedures such as intravitreal injections and laser therapy, and vitreoretinal surgery performed by 18 fellowship-trained, board-certified retina specialists across 13 Northern California clinic locations.

Product overview

Retinal Consultants Medical Group provides a unified retina care platform offering diagnostic testing, in-office treatments, and surgical procedures. The practice operates as a single integrated offering rather than a modular platform. Diagnostic services include retinal photography, angiography, ophthalmic ultrasound, OCT, and ERG/VEP testing. In-office treatments encompass intravitreal injections, laser therapies (PRP, focal laser, photodynamic therapy), and the newly available photobiomodulation therapy for dry AMD. Surgical offerings include vitrectomy and retinal detachment repair. The practice also provides AREDS/AREDS2 eye vitamins for AMD management and administered the Susvimo Port Delivery System (PDS), an FDA-approved continuous drug delivery implant for wet AMD.

Differentiator

Problem solved

Functional benefit

Products and services

• Retinal diagnostic services
• Intravitreal injection therapy
• Retinal laser therapy
• Vitreoretinal surgery
• Clinical research and trials

Quantifiable outcome

• Conducted landmark clinical trials resulting in FDA approval of pivotal drugs to treat wet macular degeneration, retinal vein occlusions, and diabetic macular edema
• +1 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

Feature7 records

Partnerships

One partnership is on record.

• Retina Consultants of AmericacoreStrategic or Co-development Partner · 1 January 2020In 2020, RCMG joined together with other elite retina-only practices to form Retina Consultants of America, now the premier national retina provider in the USA. This partnership provides access to shared resources, research capabilities, and best practices across a national network of retina specialists.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Retina Consultants of America: National network of elite retina-only practices of which RCMG is a founding member. Directly comparable operating model and patient mix; broader geographic footprint allows comparison on multi-site retina practice economics and integration.
• Byers Eye Institute at Stanford: Academic ophthalmology institute in Northern California delivering specialty retina care, clinical research, and training. Competes for tertiary referrals and clinical trial patients within RCMG's geographic footprint.

Direct peers

• Retina Vitreous Associates Medical Group: Multi-specialist retina-only medical group in Southern California offering diagnostics, intravitreal injections, laser, and vitreoretinal surgery. Closely comparable physician-staffed subspecialty practice with similar service line and referral-driven GTM.
• Mid Atlantic Retina / Wills Eye Retina Service: Multi-specialist retina group affiliated with Wills Eye Hospital delivering full-scope vitreoretinal care including clinical trials. Comparable subspecialty practice and academic-grade research operations.
• California Retina Consultants: Fellowship-trained retina specialist group with multiple California locations also under the Retina Consultants of America umbrella. Most direct operational peer given overlapping geography, service line, and parent affiliation.

Regional players

• Retina Group of New York: Long-established retina subspecialty practice serving the New York region with multiple locations. Operates the same retina-only, referral-based, fellowship-trained-physician model in a different geography.

Others

• Regeneron Pharmaceuticals: Developer of Eylea (aflibercept), the leading anti-VEGF therapy that drives a large share of intravitreal injection volume in U.S. retina practices. Not a direct competitor but critical commercial counterparty and innovation driver for RCMG's core procedure mix.
• Genentech (Roche): Developer of Lucentis and Susvimo Port Delivery System — partner on landmark clinical trials performed by RCMG physicians. Strategic supplier and clinical research collaborator underlying RCMG's treatment portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/retinalmd
• LinkedInlinkedin.com/company/2082718

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retinal Consultants Medical Group